RCM
RA Capital Management’s scPharmaceuticals SCPH Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-1,856,904
| Closed | -$13.3M | – | 67 |
|
|
2022
Q4 | $13.3M | Buy |
+1,856,904
| New | +$13.3M | 0.27% | 48 |
|
|
2022
Q2 | – | Sell |
-2,658,583
| Closed | -$15.1M | – | 97 |
|
|
2022
Q1 | $15.1M | Sell |
2,658,583
-33,187
| -1% | -$189K | 0.33% | 61 |
|
|
2021
Q4 | $13.5M | Sell |
2,691,770
-39,400
| -1% | -$198K | 0.24% | 70 |
|
|
2021
Q3 | $18.2M | Hold |
2,731,170
| – | – | 0.25% | 63 |
|
|
2021
Q2 | $16.7M | Hold |
2,731,170
| – | – | 0.27% | 60 |
|
|
2021
Q1 | $18.2M | Sell |
2,731,170
-787,828
| -22% | -$5.24M | 0.27% | 56 |
|
|
2020
Q4 | $18.6M | Hold |
3,518,998
| – | – | 0.26% | 58 |
|
|
2020
Q3 | $26.2M | Hold |
3,518,998
| – | – | 0.48% | 44 |
|
|
2020
Q2 | $25.9M | Hold |
3,518,998
| – | – | 0.5% | 37 |
|
|
2020
Q1 | $26M | Buy |
3,518,998
+271,993
| +8% | +$2.01M | 0.82% | 31 |
|
|
2019
Q4 | $18.4M | Hold |
3,247,005
| – | – | 0.56% | 27 |
|
|
2019
Q3 | $19.1M | Hold |
3,247,005
| – | – | 1.14% | 19 |
|
|
2019
Q2 | $10.4M | Buy |
3,247,005
+389,862
| +14% | +$1.24M | 0.56% | 24 |
|
|
2019
Q1 | $8.57M | Hold |
2,857,143
| – | – | 0.37% | 28 |
|
|
2018
Q4 | $10.7M | Hold |
2,857,143
| – | – | 0.63% | 24 |
|
|
2018
Q3 | $16.8M | Hold |
2,857,143
| – | – | 0.9% | 22 |
|
|
2018
Q2 | $16.2M | Hold |
2,857,143
| – | – | 1.05% | 20 |
|
|
2018
Q1 | $35.4M | Hold |
2,857,143
| – | – | 2.71% | 9 |
|
|
2017
Q4 | $34.5M | Buy |
+2,857,143
| New | +$34.5M | 2.89% | 11 |
|